Rate My Professor Emily Brooks

Brooks is an emerging leader in endocrinology research, evidenced by her growing track record of publications in high-impact peer-reviewed journals. Notable works include “Approach to the patient – disorders of salt and water balance post pituitary surgery” (The Journal of Clinical Endocrinology and Metabolism, 2023), “Copeptin is increased by nausea and vomiting during hypertonic saline infusion in healthy individuals” (Clinical Endocrinology, 2021), “Evaluation of Bayesian forecasting methods for prediction of tacrolimus exposure using samples taken on two occasions in adult kidney transplant recipients” (Therapeutic Drug Monitoring, 2020), “Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients” (Therapeutic Drug Monitoring, 2019), and “Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients” (Therapeutic Drug Monitoring, 2018). Her research specializations include pituitary conditions such as hypothalamic-pituitary-adrenal axis disorders, posterior pituitary conditions, and pituitary tumours, as well as osteoporosis. Current research is funded by a Queensland Health Clinical Research Fellowship, Endocrine Society of Australia Post-Doctoral Fellowship, RACP-ESA Research Establishment Fellowship, and two MetroSouth Research Support Scheme grants. She mentors research higher degree candidates, junior medical doctors on research projects, and physician trainees in specialty training.